Skip to main content

Table 2 Univariable analysis

From: Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials

  MaR Infarct size MSI
Coeff SE p-value Coeff SE p-value Coeff SE p-value
Age 0.0 0.1 0.866 0.1 0.1 0.213 − 0.2 0.1 0.059
Pain to balloon 0.0 0.0 0.262 0.0 0.0 0.512 −0.0 0.0 0.143
Female gender −5.0 1.5 0.001 −5.0 1.4 < 0.001 9.8 2.8 0.001
Pre PCI TnT < 15 ng/L 1.0 1.3 0.419 −1.8 1.2 0.148 5.8 2.4 0.015
LVM 0.1 0.0 0.004 0.1 0.0 < 0.001 −0.2 0.0 < 0.001
LVM/BSA 0.1 0.0 0.053 0.1 0.0 0.001 −0.3 0.1 0.001
Risk factors
 Current smoker −1.0 1.3 0.465 −2.4 1.3 0.057 3.8 2.5 0.138
 Smoker or ex-smoker −1.5 1.3 0.237 −2.8 1.2 0.021 5.3 2.4 0.030
 Diabetes −0.7 2.0 0.719 −0.1 1.9 0.972 0.0 3.8 0.997
 Hypertension 0.1 1.4 0.966 0.1 1.3 0.936 −0.2 2.7 0.929
Treatments
 Hypothermia 2.8 1.7 0.100 −0.2 1.6 0.882 3.0 3.2 0.357
 Oxygen 2.2 2.3 0.346 −0.2 2.2 0.940 3.7 5.0 0.467
 TRO40303 1.4 1.7 0.408 1.0 1.6 0.544 −1.7 3.2 0.603
Angiography
 Anterior injury 10.9 1.1 < 0.001 9.0 1.1 < 0.001 −9.4 2.4 < 0.001
 TIMI 0 3.5 1.5 0.019 5.7 1.3 < 0.001 −12.4 2.7 < 0.001
 Rentrop 0 −3.4 1.4 0.018 −2.0 1.4 0.139 0.4 2.7 0.894
  1. Pre PCI TnT < 15 ng/L = a blood sample acquired before coronary intervention showing a troponin T value < 15 ng/L, TRO40303 = the study treatment in the mitocare trial
  2. LVM left ventricular mass, BSA body surface area